Vaccines to compete for more customers

Published: 2006-10-19 07:00:00

Updated: 2006-10-19 07:00:00

GlaxoSmithKline and Merck & Co., two of the world's biggest medicine companies, will be in a competition in Korea over their main vaccines cervical cancer vaccines and rotavirus vaccines. Both companies believe their vaccines could be launched at a similar time of next year.

1) Cervical cance...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK